Arkolith/Insider Trading/NBSE/Form 4

Richman Eric I

DirectorNeuBase Therapeutics, Inc. (NBSE) · full profile →Form 4 · filed Mar 7, 2022
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2022Buy(P)1K$1.62$2K45K
Mar 3, 2022Buy(P)1K$1.72$2K44K
Mar 1, 2022Buy(P)2K$1.58$2K43K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-031172) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML